The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
Oxidized LDL and HDL: antagonists in atherothrombosis
Abstract
Increased LDL oxidation is associated with coronary artery disease. The predictive value of circulating oxidized LDL is additive to the Global Risk Assessment Score for cardiovascular risk prediction based on age, gender, total and HDL cholesterol, diabetes, hypertension, and smoking. Circulating oxidized LDL does not originate from extensive metal ion‐induced oxidation in the blood but from mild oxidation in the arterial wall by cell‐associated lipoxy‐genase and/or myeloperoxidase. Oxidized LDL induces atherosclerosis by stimulating monocyte infiltration and smooth muscle cell migration and proliferation. It contributes to atherothrombosis by inducing endothelial cell apoptosis, and thus plaque erosion, by impairing the anticoagulant balance in endothelium, stimulating tissue factor production by smooth muscle cells, and inducing apoptosis in macro‐phages. HDL cholesterol levels are inversely related to risk of coronary artery disease. HDL prevents atherosclerosis by reverting the stimulatory effect of oxidized LDL on monocyte infiltration. The HDL‐associated enzyme paraoxonase inhibits the oxidation of LDL. PAF‐acetyl hydrolase, which circulates in association with HDL and is produced in the arterial wall by macrophages, degrades bioactive oxidized phospholip‐ids. Both enzymes actively protect hypercholester‐olemic mice against atherosclerosis. Oxidized LDL inhibits these enzymes. Thus, oxidized LDL and HDL are indeed antagonists in the development of cardiovascular disease.—Mertens, A., Hobvoet, P. Oxidized LDL and HDL: antagonists in atherothrombosis. FASEB J. 15, 2073–2084 (2001)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
Rubins, H. B., Robins, S. J., Collins, D., Fye, C. L., Anderson, J. W., Elam, M. B., Faas, F. H., Linares, E., Schaefer, E. J., Schectman, G., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410604 · Cited by 3,439
Goldstein, J. L., Ho, Y. K., Basu, S. K., & Brown, M. S. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.1.333 · Cited by 2,448
Transforming growth factor beta
(2011) · SpringerReference · doi:10.1007/springerreference_39918 · Cited by 1,944
Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels: The Framingham Study
Castelli, W. P. (1986) · JAMA · doi:10.1001/jama.1986.03380200073024 · Cited by 1,611
An endothelial receptor for oxidized low-density lipoprotein
Sawamura, T., Kume, N., Aoyama, T., Moriwaki, H., Hoshikawa, H., Aiba, Y., Tanaka, T., Miwa, S., Katsura, Y., Kita, T., et al. (1997) · Nature · doi:10.1038/386073a0 · Cited by 1,385
Autoantibody against oxidised LDL and progression of carotid atherosclerosis
Salonen, J. T., Korpela, H., Salonen, R., Nyyssonen, K., Yla-Herttuala, S., Yamamoto, R., Butler, S., Palinski, W., & Witztum, J. L. (1992) · The Lancet · doi:10.1016/0140-6736(92)90926-t · Cited by 1,316
Grundy, S. M., Pasternak, R., Greenland, P., Smith, S., & Fuster, V. (1999) · Circulation · doi:10.1161/01.cir.100.13.1481 · Cited by 1,315
Aviram, M., Rosenblat, M., Bisgaier, C. L., Newton, R. S., Primo-Parmo, S. L., & La Du, B. N. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1649 · Cited by 1,168
Watson, A. D., Berliner, J. A., Hama, S. Y., La Du, B. N., Faull, K. F., Fogelman, A. M., & Navab, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118359 · Cited by 1,154
Cushing, S. D., Berliner, J. A., Valente, A. J., Territo, M. C., Navab, M., Parhami, F., Gerrity, R., Schwartz, C. J., & Fogelman, A. M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5134 · Cited by 1,146
Stampfer, M. J. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540110036029 · Cited by 1,079
Lamarche, B., Tchernof, A., Moorjani, S., Cantin, B., Dagenais, G. R., Lupien, P. J., & Despre´s, J.-P. (1997) · Circulation · doi:10.1161/01.cir.95.1.69 · Cited by 1,077
Febbraio, M., Podrez, E. A., Smith, J. D., Hajjar, D. P., Hazen, S. L., Hoff, H. F., Sharma, K., & Silverstein, R. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9259 · Cited by 1,044
Gardner, C. D. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540110029028 · Cited by 843
MACKNESS, M., ARROL, S., ABBOTT, C., & DURRINGTON, P. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90183-u · Cited by 816
High-Density Lipoproteins Inhibit Cytokine-Induced Expression of Endothelial Cell Adhesion Molecules
Cockerill, G. W., Rye, K.-A., Gamble, J. R., Vadas, M. A., & Barter, P. J. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.11.1987 · Cited by 783
Rajavashisth, T. B., Andalibi, A., Territo, M. C., Berliner, J. A., Navab, M., Fogelman, A. M., & Lusis, A. J. (1990) · Nature · doi:10.1038/344254a0 · Cited by 776
Watson, A. D., Leitinger, N., Navab, M., Faull, K. F., Hörkkö, S., Witztum, J. L., Palinski, W., Schwenke, D., Salomon, R. G., Sha, W., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.21.13597 · Cited by 753
Laursen, J. B., Somers, M., Kurz, S., McCann, L., Warnholtz, A., Freeman, B. A., Tarpey, M., Fukai, T., & Harrison, D. G. (2001) · Circulation · doi:10.1161/01.cir.103.9.1282 · Cited by 721
de Graaf, J., Hak-Lemmers, H. L., Hectors, M. P., Demacker, P. N., Hendriks, J. C., & Stalenhoef, A. F. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.2.298 · Cited by 714
Sugiyama, S., Okada, Y., Sukhova, G. K., Virmani, R., Heinecke, J. W., & Libby, P. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64036-9 · Cited by 699
Holvoet, P., Vanhaecke, J., Janssens, S., Van de Werf, F., & Collen, D. (1998) · Circulation · doi:10.1161/01.cir.98.15.1487 · Cited by 673
Self-citationNavab, M., Hama, S. Y., Anantharamaiah, G. M., Hassan, K., Hough, G. P., Watson, A. D., Reddy, S. T., Sevanian, A., Fonarow, G. C., & Fogelman, A. M. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33462-3 · Cited by 668
Oxidized Low-density Lipoprotein Decreases the Expression of Endothelial Nitric Oxide Synthase
Liao, J. K., Shin, W. S., Lee, W. Y., & Clark, S. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.1.319 · Cited by 541
Circulating Oxidized LDL Is a Useful Marker for Identifying Patients With Coronary Artery Disease
Holvoet, P., Mertens, A., Verhamme, P., Bogaerts, K., Beyens, G., Verhaeghe, R., Collen, D., Muls, E., & Van de Werf, F. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.5.844 · Cited by 530
Self-citationAnti-inflammatory properties of a platelet-activating factor acetylhydrolase
Tjoelker, L. W., Wilder, C., Eberhardt, C., Stafforinit, D. M., Dietsch, G., Schimpf, B., Hooper, S., Trong, H. L., Cousens, L. S., Zimmerman, G. A., et al. (1995) · Nature · doi:10.1038/374549a0 · Cited by 526
Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E–deficient mice
Cyrus, T., Witztum, J. L., Rader, D. J., Tangirala, R., Fazio, S., Linton, M. F., & Funk, C. D. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5897 · Cited by 523
Role of basic fibroblast growth factor in vascular lesion formation.
Lindner, V, Lappi, D. A., Baird, A., Majack, R. A., & Reidy, M. A. (1991) · Circulation Research · doi:10.1161/01.res.68.1.106 · Cited by 517
Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro
Podrez, E. A., Schmitt, D., Hoff, H. F., & Hazen, S. L. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5549 · Cited by 492
Podrez, E. A., Febbraio, M., Sheibani, N., Schmitt, D., Silverstein, R. L., Hajjar, D. P., Cohen, P. A., Frazier, W. A., Hoff, H. F., & Hazen, S. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8574 · Cited by 455
Shih, D. M., Xia, Y.-R., Wang, X.-P., Miller, E., Castellani, L. W., Subbanagounder, G., Cheroutre, H., Faull, K. F., Berliner, J. A., Witztum, J. L., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910376199 · Cited by 425
Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300
Horvai, A. E., Xu, L., Korzus, E., Brard, G., Kalafus, D., Mullen, T.-M., Rose, D. W., Rosenfeld, M. G., & Glass, C. K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1074 · Cited by 422
[1] Introduction to the plasma lipoproteins
Gotto, A. M., Pownall, H. J., & Havel, R. J. (1986) · Methods in Enzymology · doi:10.1016/0076-6879(86)28061-1 · Cited by 421
Lamarche, B. (1998) · JAMA · doi:10.1001/jama.279.24.1955 · Cited by 417
A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein.
Parthasarathy, S., Wieland, E., & Steinberg, D. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.3.1046 · Cited by 415
Toshima, S.-I., Hasegawa, A., Kurabayashi, M., Itabe, H., Takano, T., Sugano, J., Shimamura, K., Kimura, J., Michishita, I., Suzuki, T., et al. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.10.2243 · Cited by 407
Stafforini, D. M., McIntyre, T. M., Carter, M. E., & Prescott, S. M. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61335-3 · Cited by 398
Carr, A. C., McCall, M. R., & Frei, B. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.7.1716 · Cited by 386
Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL
Calvo, D., Gómez-Coronado, D., Suárez, Y., Lasunción, M. A., & Vega, M. A. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32566-9 · Cited by 381
Clinton, S. K., Underwood, R., Hayes, L., Sherman, M. L., Kufe, D. W., & Libby, P. (1992) · PubMed · Cited by 377
Newby, A. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00286-7 · Cited by 362
Boulanger, C. M., Tanner, F. C., Béa, M. L., Hahn, A. W., Werner, A., & Lüscher, T. F. (1992) · Circulation Research · doi:10.1161/01.res.70.6.1191 · Cited by 352
Li, D., & Mehta, J. L. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.4.1116 · Cited by 335
Nigon, F., Lesnik, P., Rouis, M., & Chapman, M. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41629-3 · Cited by 326
Increased atherosclerosis in myeloperoxidase-deficient mice
Brennan, M.-L., Anderson, M. M., Shih, D. M., Qu, X.-D., Wang, X., Mehta, A. C., Lim, L. L., Shi, W., Hazen, S. L., Jacob, J. S., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci8797 · Cited by 323
Inducible Expression of Lectin-like Oxidized LDL Receptor-1 in Vascular Endothelial Cells
Kume, N., Murase, T., Moriwaki, H., Aoyama, T., Sawamura, T., Masaki, T., & Kita, T. (1998) · Circulation Research · doi:10.1161/01.res.83.3.322 · Cited by 321
Uittenbogaard, A., Shaul, P. W., Yuhanna, I. S., Blair, A., & Smart, E. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.11278 · Cited by 310
Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio.
Navab, M., Hama-Levy, S., Van Lenten, B. J., Fonarow, G. C., Cardinez, C. J., Castellani, L. W., Brennan, M. L., Lusis, A. J., Fogelman, A. M., & La Du, B. N. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119369 · Cited by 309
Xu, X.-P., Meisel, S. R., Ong, J. M., Kaul, S., Cercek, B., Rajavashisth, T. B., Sharifi, B., & Shah, P. K. (1999) · Circulation · doi:10.1161/01.cir.99.8.993 · Cited by 298
Bergmark, C., Wu, R., Faire, U. D., Lefvert, A. K., & Swedenborg, J. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.4.441 · Cited by 280
Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis
Heinecke, J. W. (1997) · Current Opinion in Lipidology · doi:10.1097/00041433-199710000-00005 · Cited by 273
Frei, B., & Gaziano, J. M. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)35354-2 · Cited by 270
Malle, E., Waeg, G., Schreiber, R., Gröne, E. F., Sattler, W., & Gröne, H. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01498.x · Cited by 245
Ivandic, B., Castellani, L. W., Wang, X.-P., Qiao, J.-H., Mehrabian, M., Navab, M., Fogelman, A. M., Grass, D. S., Swanson, M. E., de Beer, M. C., et al. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.5.1284 · Cited by 244
Leitinger, N., Tyner, T. R., Oslund, L., Rizza, C., Subbanagounder, G., Lee, H., Shih, P. T., Mackman, N., Tigyi, G., Territo, M. C., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.12010 · Cited by 242
Harats, D., Shaish, A., George, J., Mulkins, M., Kurihara, H., Levkovitz, H., & Sigal, E. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.9.2100 · Cited by 238
Apoptosis in the Atherosclerotic Plaque: Quantitative and Qualitative Aspects
Kockx, M. M. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.10.1519 · Cited by 234
Cominacini, L., Garbin, U., Pasini, A. F., Davoli, A., Campagnola, M., Contessi, G. B., Pastorino, A. M., & Lo Cascio, V. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00271-7 · Cited by 230
Rankin, S., Parthasarathy, S., & Steinberg, D. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42068-1 · Cited by 219
Murase, T., Kume, N., Korenaga, R., Ando, J., Sawamura, T., Masaki, T., & Kita, T. (1998) · Circulation Research · doi:10.1161/01.res.83.3.328 · Cited by 216
Human Plasma Platelet-Activating Factor Acetyl hydrolase
Stafforini, D. M., & Tjoelker, L. W. (2003) · Lipase and Phospholipase Protocols · doi:10.1385/1-59259-581-2:49 · Cited by 216
Lehtimäki, T., Lehtinen, S., Solakivi, T., Nikkilä, M., Jaakkola, O., Jokela, H., Ylä-Herttuala, S., Luoma, J. S., Koivula, T., & Nikkari, T. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.1.23 · Cited by 202
Napoli, C., Quehenberger, O., De Nigris, F., Abete, P., Glass, C. K., & Palinski, W. (2000) · The FASEB Journal · doi:10.1096/fj.99-0986com · Cited by 199
Tselepis, A. D., Dentan, C., Karabina, S.-A. P., Chapman, M. J., & Ninio, E. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.10.1764 · Cited by 198
Yoshida, H., Quehenberger, O., Kondratenko, N., Green, S., & Steinberg, D. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.5.794 · Cited by 194
Quarck, R., De Geest, B., Stengel, D., Mertens, A., Lox, M., Theilmeier, G., Michiels, C., Raes, M., Bult, H., Collen, D., et al. (2001) · Circulation · doi:10.1161/01.cir.103.20.2495 · Cited by 193
Self-citationLi, H., Freeman, M. W., & Libby, P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117628 · Cited by 179
Holvoet, P., Donck, J., Landeloos, M., Brouwers, E., Luijtens, K., Arnout, J., Lesaffre, E., Vanrenterghem, Y., & Collen, D. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650639 · Cited by 178
Self-citationOxidized Low Density Lipoproteins in Patients With Transplant-Associated Coronary Artery Disease
Holvoet, P., Stassen, J.-M., Van Cleemput, J., Collen, D., & Vanhaecke, J. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.1.100 · Cited by 177
Self-citationAccelerated Atherosclerosis in Mice Lacking Tumor Necrosis Factor Receptor p55
Schreyer, S. A., Peschon, J. J., & LeBoeuf, R. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.42.26174 · Cited by 176
Stiko-Rahm, A., Hultgårdh-Nilsson, A., Regnström, J., Hamsten, A., & Nilsson, J. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.9.1099 · Cited by 166
Leitinger, N., Watson, A. D., Hama, S. Y., Ivandic, B., Qiao, J.-H., Huber, J., Faull, K. F., Grass, D., Navab, M., Fogelman, A. M., et al. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.5.1291 · Cited by 154
Platelet‐activating factor: a mediator for clinicians
Imaizumi, T., Stafforini, D. M., Yamada, Y., et al. (1995) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1995.tb00894.x · Cited by 148
Nitric Oxide Regulation of Free Radical– and Enzyme-Mediated Lipid and Lipoprotein Oxidation
Bloodsworth, A., O’Donnell, V. B., & Freeman, B. Α. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.7.1707 · Cited by 147
Toikka, J., Ahotupa, M. O., Viikari, J. S. A., Niinikoski, H., Taskinen, M., Irjala, K., Hartiala, J., & Raitakari, O. T. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00186-0 · Cited by 143
Subbanagounder, G., Leitinger, N., Shih, P. T., Faull, K. F., & Berliner, J. A. (1999) · Circulation Research · doi:10.1161/01.res.85.4.311 · Cited by 138
Kugiyama, K., Sakamoto, T., Misumi, I., Sugiyama, S., Ohgushi, M., Ogawa, H., HORIGUCHI, M., & Yasue, H. (1993) · Circulation Research · doi:10.1161/01.res.73.2.335 · Cited by 135
Uusitupa, M. I. J., NISKANEN, L. K., Luoma, J., Vilja, P. J., Mercuri, M. F., Rauramaa, R., & Ylä‐Herttuala, S. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.10.1236 · Cited by 134
HDLassociated PAF‐AH reduces endothelial adhesiveness in apoE −/− mice
Theilmeier, G., Geest, B. D., Veldhoven, P. P. V., Stengel, D., Michiels, C., Lox, M., Landeloos, M., Chapman, M. J., Ninio, E., Collen, D., et al. (2000) · The FASEB Journal · doi:10.1096/fj.99-1029com · Cited by 133
Self-citationMarathe, S. V., Kuriakose, G., Williams, K. J., & Tabas, I. A. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.11.2648 · Cited by 128
Kohno, M., Yokokawa, K., Yasunari, K., et al. (1998) · Circulation · doi:10.1161/01.cir.98.4.353 · Cited by 127
Thrombosis and atherosclerosis
Holvoet, P., & Collen, D. (1997) · Current Opinion in Lipidology · doi:10.1097/00041433-199710000-00012 · Cited by 125
Self-citationRedox-Sensitive Regulation of LOX-1 Gene Expression in Vascular Endothelium
Nagase, M., Ando, K., Nagase, T., Kaname, S., Sawamura, T., & Fujita, T. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4374 · Cited by 120
Mechanisms of the pro- and anti-oxidant actions of nitric oxide in atherosclerosis
Patel, R. P., Levonen, A., Crawford, J. H., & Darley-Usmar, V. M. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00086-9 · Cited by 119
Transforming growth factor-beta 1 inhibits scavenger receptor activity in THP-1 human macrophages.
Bottalico, L. A., Wager, R. E., Agellon, L. B., Assoian, R. K., & Tabas, I. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54434-3 · Cited by 114
LOX‐1 mediates lysophosphatidylcholine‐induced oxidized LDL uptake in smooth muscle cells
Aoyama, T., Chen, M., Fujiwara, H., Masaki, Τ., & Sawamura, T. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01154-6 · Cited by 110
Kume, N., Moriwaki, H., Kataoka, H., Minami, M., Murase, T., Sawamura, T., Masaki, Τ., & Kita, T. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06332.x · Cited by 107
Holvoet, P., Cleemput, J. V., Collen, D., & Vanhaecke, J. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.3.698 · Cited by 105
Self-citationMinami, M., Kume, N., Kataoka, H., Morimoto, M., Hayashida, K., Sawamura, T., Masaki, T., & Kita, T. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2778 · Cited by 102
Vidal, F., Colomé, C., Martínez‐González, J., & Badimón, L. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2520378.x · Cited by 97
Geest, B. D., Zhao, Z., Collen, D., & Holvoet, P. (1997) · Circulation · doi:10.1161/01.cir.96.12.4349 · Cited by 96
Self-citationVohl, M., Neville, T. A.-M., Kumarathasan, R., Braschi, S., & Sparks, D. L. (1999) · Biochemistry · doi:10.1021/bi982258w · Cited by 92
Platelet-activating factor (PAF): Implications for coronary heart and vascular diseases
Evangelou, A. M. (1994) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/0952-3278(94)90101-5 · Cited by 91
Desrumaux, C. M., Deckert, V., Athias, A., Masson, D., Lizard, G., Palleau, V., Gambert, P., & Lagrost, L. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.8.883 · Cited by 90
Orchard, T. J., Virella, G., Forrest, K. Y. Z., Evans, R. W., Becker, D., & Lopes-Virella, M. F. (1999) · Diabetes · doi:10.2337/diabetes.48.7.1454 · Cited by 89
Hedrick, C. C., Hassan, K., Hough, G. P., Yoo, J., Simzar, S., Quinto, C. R., Kim, S.-M., Dooley, A. N., Langi, S., Hama, S. Y., et al. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.8.1946 · Cited by 89
Metzler, B., Hu, Y., Dietrich, H., & Xu, Q. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65061-4 · Cited by 85
Direct measurement of nitric oxide release from vascular endothelial cells
Guo, J. P., Murohara, T., Buerke, M., Scalia, R. G., & Lefer, A. M. (1996) · Journal of Applied Physiology · doi:10.1152/jappl.1996.81.2.774 · Cited by 82
Nitric oxide donor GEA 3162 inhibits endothelial cell‐mediated oxidation of low density lipoprotein
Malo‐Ranta, U., Ylä‐Herttuala, S., Metsä‐Ketelä, T., Jaakkola, O., Moilanen, E., Vuorinen, P., & Nikkari, T. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80269-6 · Cited by 79
Kohno, H., Sueshige, N., Oguri, K., Izumidate, H., Masunari, T., Kawamura, M., Itabe, H., Takano, T., Hasegawa, A., & Nagai, R. (2000) · Clinical Biochemistry · doi:10.1016/s0009-9120(00)00065-5 · Cited by 73
Upston, J. M., Neužil, J., Witting, P. K., Alleva, R., & Stocker, R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.48.30067 · Cited by 70
Heller, J. I., Crowley, J. R., Hazen, S. L., Salvay, D. M., Wagner, P. D., Pennathur, S., & Heinecke, J. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.9957 · Cited by 69
Evidence that lipid hydroperoxides inhibit plasma lecithin:cholesterol acyltransferase activity
Bielicki, J. K., & Forte, T. M. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32130-1 · Cited by 67
Dhaliwal, B. S., & Steinbrecher, U. P. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31999-4 · Cited by 65
Tissue Factor Pathway Inhibitor Is Expressed by Human Monocyte–Derived Macrophages
Petit, L., Lesnik, P., Dachet, C., Moreau, M., & Chapman, M. J. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.2.309 · Cited by 65
Ishii, H., Kizaki, K., Horie, S., & Kazama, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.14.8458 · Cited by 55
Penn, M. S., Cui, M., Winokur, A. L., Bethea, J. R., Hamilton, T. A., DiCorleto, P. E., & Chisolm, G. M. (2000) · Blood · doi:10.1182/blood.v96.9.3056 · Cited by 52
Anthonsen, M. W., Stengel, D., Hourton, D., Ninio, E., & Johansen, B. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.5.1276 · Cited by 50
Allison, B., Nilsson, L., Karpe, F., Hamsten, A., & Eriksson, P. O. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.5.1354 · Cited by 47
Rikitake, Y., Hirata, K., Kawashima, S., Akita, H., & Yokoyama, M. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00186-x · Cited by 47
Carr, A. C., & Frei, B. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009082200 · Cited by 46
Oxidized LDL Suppresses NF-κB and Overcomes Protection from Apoptosis in Activated Endothelial Cells
Heermeier, K., LEICHT, W., Palmetshofer, A., ULLRICH, M., Wanner, C., & Galle, J. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v123456 · Cited by 44
Oxidation of Apolipoprotein B-100 in Circulating LDL Is Related to LDL Residence Time
Pietzsch, J., Lattke, P., & Julius, U. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.10.e63 · Cited by 43
Esaki, T., Hayashi, T., Muto, E., et al. (2000) · Nitric Oxide · doi:10.1006/niox.2000.0311 · Cited by 41
HDL Cholesterol Level Predicts Survival in Men After Coronary Artery Bypass Graft Surgery
Foody, J. M., Ferdinand, F. D., Pearce, G. L., Lytle, B. W., Cosgrove, D. M., & Sprecher, D. L. (2000) · Circulation · doi:10.1161/01.cir.102.suppl_3.iii-90 · Cited by 40
Gräfe, M., Auch–Schwelk, W., Hertel, H., Terbeek, D., Steinheider, G., Loebe, M. M., & Fleck, E. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00258-x · Cited by 32
Pietzsch, J. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2533 · Cited by 32
12-Lipoxygenase Products Increase Monocyte: Endothelial Interactions
Hedrick, C. C., Kim, M. D., Natarajan, R. D., et al. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4793-8_67 · Cited by 29
Farber, A. M., Kitzmiller, T. J., Morganelli, P. M., Pfeiffer, J. R., Groveman, D. S., Wagner, R. J., Cronenwett, J. L., & Powell, R. J. (1999) · Journal of Surgical Research · doi:10.1006/jsre.1999.5663 · Cited by 23
Kim, J. G., Taylor, W. R., & Parthasarathy, S. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(98)00320-7 · Cited by 22
The mouse plasma PAF acetylhydrolase: II. It consists of two enzymes both associated with the HDL.
Tsaoussis, V., & VAKIRTZI-LEMONIAS, C. (1994) · PubMed · Cited by 20
Modulators of Oxidized LDL-Induced Hyperadhesiveness in Human Endothelial Cells
Maier, J. A. M., Barenghi, L., Bradamante, S., et al. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2512 · Cited by 19
Holvoet, P., Danloy, S., Deridder, E., Lox, M., Bernar, H., Dhoest, A., & Collen, D. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3038 · Cited by 16
Self-citation
Cited by
Pisoschi, A. M., Pop, A., Iordache, F., Stanca, L., Predoi, G., & Serban, A. I. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112891 · Cited by 816
Biological markers of oxidative stress: Applications to cardiovascular research and practice
Ho, E., Karimi Galougahi, K., Liu, C.-C., Bhindi, R., & Figtree, G. A. (2013) · Redox Biology · doi:10.1016/j.redox.2013.07.006 · Cited by 811
Zalewski, A., & Macphee, C. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000160551.21962.a7 · Cited by 474
Myeloperoxidase – A bridge linking inflammation and oxidative stress with cardiovascular disease
Ndrepepa, G. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.02.022 · Cited by 447
Effects of Thyroid Dysfunction on Lipid Profile
Rizos, C. V., Elisaf, M. S., & Liberopoulos, E. N. (2011) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401105010076 · Cited by 392
Metadata
- Authors
- Mertens, A., & Holvoet, P.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2001-10
- Volume
- 15
- Issue
- 12
- Pages
- 2073-2084
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2080904659
- Cited by
- 414
- References
- 125
- FWCI
- 5.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.